(Q37776088)

23 August 2017

title

Adrenergic signaling polymorphisms and their impact on cardiovascular disease (English)

1 reference

23 August 2017

Adrenergic Signaling Polymorphisms and Their Impact on Cardiovascular Disease (English)

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

11 June 2024

author name string

Gerald W. Dorn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664078

11 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20664078

11 June 2024

publication date

1 July 2010

1 reference

full work available at URL

23 August 2017

http://intl-physrev.physiology.org/cgi/content/abstract/90/3/1013

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664078

https://www.physiology.org/doi/pdf/10.1152/physrev.00001.2010

11 June 2024

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

11 June 2024

published in

Physiological Reviews

1 reference

23 August 2017

volume

90

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

1013-1062

1 reference

Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Alpha(1)-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta-adrenergic receptor kinase: primary structure delineates a multigene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Induction of the skeletal alpha-actin gene in alpha 1-adrenoceptor-mediated hypertrophy of rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The 825C/T polymorphism of the G-protein subunit beta3 is not related to hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

STUDIES ON THE FUNCTION OF THE ADRENERGIC NERVE ENDINGS IN THE HEART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Antiadrenergic therapy of chronic heart failure: surprises and new opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Reduced beta 1 receptor messenger RNA abundance in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta(2)-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The Gln27Glu beta2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

beta-2 adrenergic receptor gene variations, blood pressure, and heart size in normal twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Alpha2cDel322-325 and beta1Arg389 adrenergic polymorphisms are not associated with reduced left ventricular ejection fraction or increased left ventricular volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cloning, characterisation and identification of several polymorphisms in the promoter region of the human alpha2B-adrenergic receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Pure β-adrenergic receptor: the single polypeptide confers catecholamine responsiveness to adenylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Multiple genes for essential-hypertension susceptibility on chromosome 1q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Translating insights from the cancer genome into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Rgs5 targeting leads to chronic low blood pressure and a lean body habitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Targeted disruption of the beta2 adrenergic receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cloning and sequence analysis of the human brain β-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Adverse mortality effect of central sympathetic inhibition with sustained‐release moxonidine in patients with heart failure (MOXCON)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Clinical and genetic modifiers of long-term survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Transgenic Galphaq overexpression induces cardiac contractile failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Transgenic mice overexpressing alpha2A-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Model systems for the study of seven-transmembrane-segment receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

GRK mythology: G-protein receptor kinases in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Novel pharmacotherapies to abrogate postinfarction ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Protein kinase cascades in the regulation of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The fuzzy logic of physiological cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Arg16/Gly beta2-adrenergic receptor polymorphism alters the cardiac output response to isometric exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Molecular characterization of the human beta 3-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Characterization of adrenoceptors mediating positive inotropic responses in the ventricular myocardium of the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Alternative signaling: cardiomyocyte beta1-adrenergic receptors signal through EGFRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Clinical and hemodynamic appraisal of beta adrenergic blocking drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A genome-wide association study of northwestern Europeans involves the C-type natriuretic peptide signaling pathway in the etiology of human height variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Mechanisms involved in alpha-adrenergic phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Altered glucose homeostasis in alpha2A-adrenoceptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Comparison of the beneficial effect of beta-blockers on mortality in patients with ischaemic or non-ischaemic systolic heart failure: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

G protein-coupled receptor kinase 4 gene variants in human essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A genetic polymorphism of the alpha2-adrenergic receptor increases autonomic responses to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cardioprotection specific for the G protein G i2 in chronic adrenergic signaling through β 2 -adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The Neurohumoral Axis in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Regulation of G protein-coupled receptor kinase 5 (GRK5) by actin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association of alpha1a-adrenergic receptor polymorphism and blood pressure phenotypes in the Brazilian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

-391 C to G substitution in the regulator of G-protein signalling-2 promoter increases susceptibility to the metabolic syndrome in white European men: consistency between molecular and epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Role of alpha2-adrenergic receptors in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The alpha2 -adrenergic receptors in hypertension and heart failure: experimental and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

beta2-Adrenergic receptor gene variations associated with stage-2 hypertension in northern Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

G proteins: transducers of receptor-generated signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association of alpha1A adrenergic receptor gene variants on chromosome 8p21 with human stage 2 hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cardiovascular injury induced by sympathetic catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association of beta1-adrenergic receptor genetic polymorphism with mental stress-induced myocardial ischemia in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cardiac-specific overexpression of human beta2 adrenoceptors in mice exposes coupling to both Gs and Gi proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Crosstalk of beta-adrenergic receptor subtypes through Gi blunts beta-adrenergic stimulation of L-type Ca2+ channels in canine heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A contemporary approach to hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Akt-mediated cardiomyocyte survival pathways are compromised by G alpha q-induced phosphoinositide 4,5-bisphosphate depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Alpha- and beta-adrenergic receptor polymorphisms in hypertensive and normotensive offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Individual and joint association of alpha1A-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association analysis of Arg16Gly polymorphism of the beta2-adrenergic receptor gene in offspring from hypertensive and normotensive families

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

G protein-coupled receptor kinase 5 contains a DNA-binding nuclear localization sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Markedly reduced effects of (-)-isoprenaline but not of (-)-CGP12177 and unchanged affinity of beta-blockers at Gly389-beta1-adrenoceptors compared to Arg389-beta1-adrenoceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

CYP2D6 phenotype prediction from genotype: which system is the best?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Facilitation of vagal reflex bradycardia by an action of clonidine on central -receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cloning and expression of GRK5: a member of the G protein-coupled receptor kinase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Effect of the alpha2C-adrenoreceptor deletion322-325 variant on sympathetic activity and cardiovascular measures in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Insertion/deletion polymorphism in alpha2-adrenergic receptor gene is a genetic risk factor for sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

RGS2: a "turn-off" in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association of Parental Heart Failure with Risk of Heart Failure in Offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Seven transmembrane receptors: something old, something new.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A novel missense mutation in ADRB3 increases risk for type 2 diabetes in a Mexican American family

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Genome-wide association scan for stature in Chinese: evidence for ethnic specific loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The Arg389Gly beta1-adrenoceptor polymorphism does not affect cardiac effects of exercise after parasympathetic inhibition by atropine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Autoimmune diseases: insights from genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The diploid genome sequence of an individual human

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A functional polymorphism of the Galphaq (GNAQ) gene is associated with accelerated mortality in African-American heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Gly389Arg polymorphism of β1-adrenergic receptor is associated with the cardiovascular response to metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Agonist dose-dependent phosphorylation by protein kinase A and G protein-coupled receptor kinase regulates beta2 adrenoceptor coupling to G(i) proteins in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Novel and nondetected human signaling protein polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The role of inositol 1,4,5-trisphosphate receptors in Ca(2+) signalling and the generation of arrhythmias in rat atrial myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Central hypotensive effects of the alpha2a-adrenergic receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cardiac signaling genes exhibit unexpected sequence diversity in sporadic cardiomyopathy, revealing HSPB7 polymorphisms associated with disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Variability within alpha- and beta-adrenoreceptor genes as a predictor of cardiovascular function at rest and in response to mental challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A common allele on chromosome 9 associated with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Lack of association between certain candidate gene polymorphisms and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

β1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cytoplasmic signaling pathways that regulate cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Variation in the alpha2B-adrenergic receptor gene (ADRA2B) and its relationship to vascular response in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Alpha2B adrenergic receptor 301-303 deletion polymorphism and vascular alpha2 adrenergic receptor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

No positive association between adrenergic receptor variants of alpha2cDel322-325, beta1Ser49, beta1Arg389 and the risk for heart failure in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Mutagenesis of the beta2-Adrenergic Receptor: How Structure Elucidates Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The glycine allele of a glycine/arginine polymorphism in the beta2-adrenergic receptor gene is associated with essential hypertension in a population of Chinese origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Hierarchy of polymorphic variation and desensitization permutations relative to beta 1- and beta 2-adrenergic receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Clinical pharmacokinetics of metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Alpha2C-adrenoceptor polymorphism is associated with improved event-free survival in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Multi-tasking RGS proteins in the heart: the next therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Adenyl cyclase as an adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Seven-transmembrane-spanning receptors and heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Regulation of G protein-coupled receptor kinase subtypes by calcium sensor proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Confirmation of a role for the 389R>G beta-1 adrenoceptor polymorphism on exercise capacity in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

164Ile allele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

CYP2D6 genotype and its relationship with metoprolol dose, concentrations and effect in patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Lack of association between genetic variation in the beta3-adrenergic receptor gene and insulin resistance in patients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association between hypertension and the alpha-adducin, beta1-adrenoreceptor, and G-protein beta3 subunit genes in the Japanese population; the Suita study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Molecular genetics of G proteins and atherosclerosis risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association of a human G-protein beta3 subunit variant with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The consensus coding sequences of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Complex haplotypes derived from noncoding polymorphisms of the intronless alpha2A-adrenergic gene diversify receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

An insertion/deletion polymorphism in the α2b-adrenergic receptor gene is a novel genetic risk factor for acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta2-adrenergic receptor gene and resting hemodynamics in European and African American youth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Albright's hereditary osteodystrophy and defective G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cardiac failure with propranolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Signaling in myocardial hypertrophy: life after calcineurin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Differential coupling of Arg- and Gly389 polymorphic forms of the beta1-adrenergic receptor leads to pathogenic cardiac gene regulatory programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Colles-Stokes contributions to the concept of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Treatment of heart failure according to William Stokes: the enchanted mercury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Functional variant in the (alpha)2B adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A genome wide scan for early onset primary hypertension in Scandinavians

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of beta2-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Association study of G protein-coupled receptor kinase 4 gene variants with essential hypertension in northern Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Cytochrome P450 2D6 and antidepressant toxicity and response: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Genetic diseases associated with heterotrimeric G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The complete genome of an individual by massively parallel DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Neurohumoral features of myocardial stunning due to sudden emotional stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

The role of race in heart failure therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

T64A polymorphism in beta3-adrenergic receptor gene (ADRB3) and coronary heart disease: a case-cohort study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Protein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Haplotype analysis of the beta2 adrenergic receptor gene and risk of myocardial infarction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Admixture mapping for hypertension loci with genome-scan markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Inositol-1,4,5-trisphosphate-dependent Ca(2+) signalling in cat atrial excitation-contraction coupling and arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Role of ?1- and ?2-adrenoceptor polymorphisms in heart failure: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

Endothelial β2 adrenergic signaling to AKT: Role of Gi and SRC

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00001.2010

21 January 2018

Freely associating

1

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Adrenergic receptors: a personal and practical view

11 June 2024

4

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy

11 June 2024

5

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Polymorphism in the beta(1)-adrenergic receptor gene and hypertension

11 June 2024

9

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

11 June 2024

14

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension

11 June 2024

20

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

11 June 2024

24

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

11 June 2024

25

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Alpha-adrenoceptor-mediated positive inotropic effect of phenylephrine in isolated human ventricular myocardium.

11 June 2024

32

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes

11 June 2024

40

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5

11 June 2024

41

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein

11 June 2024

52

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease

11 June 2024

59

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Phenotyping hypertrophy: eschew obfuscation

11 June 2024

70

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

11 June 2024

Pharmacological Reviews

87

53

1

Ferguson SS

2001

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy

11 June 2024

92

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Genetic polymorphism of the alpha 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans

11 June 2024

95

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure

11 June 2024

100

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

The beta2-adrenoceptor gene and hypertension: is it the promoter or the coding region or neither?

11 June 2024

112

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy

11 June 2024

118

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Polymorphisms of the beta2 -adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies

11 June 2024

120

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

11 June 2024

Pharmacological Reviews

122

47

267

Hieble JP

1995

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Blockade of both alpha1A- and alpha1B-adrenergic receptor subtype signaling is required to inhibit neointimal formation in the mouse femoral artery

11 June 2024

128

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes

11 June 2024

133

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

The Glu27 allele of the ??2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension

11 June 2024

135

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Association of the G(s)alpha gene with essential hypertension and response to beta-blockade

11 June 2024

138

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Use of genetics in the clinical evaluation of cardiomyopathy

11 June 2024

144

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Association analysis of beta(2)-adrenergic receptor polymorphisms with hypertension in Japanese

11 June 2024

148

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Identification of hypertension-susceptibility genes and pathways by a systemic multiple candidate gene approach: the millennium genome project for hypertension

11 June 2024

156

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome

11 June 2024

161

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Oxidation phenotype--a major determinant of metoprolol metabolism and response

11 June 2024

172

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Do allelic variants in alpha2A and alpha2C adrenergic receptors predispose to hypertension in blacks?

11 June 2024

176

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level

11 June 2024

180

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Ile164 variant of β2-adrenoceptor does not influence outcome in heart failure but may interact with β blocker treatment

11 June 2024

186

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure

11 June 2024

190

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Role of the α 2B -Adrenergic Receptor in the Development of Salt-Induced Hypertension

11 June 2024

198

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

11 June 2024

200

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Functional correlates of alpha(2A)-adrenoceptor gene polymorphism in the HANE study

11 June 2024

212

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

(-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through β2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling

11 June 2024

216

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

The fatal embrace: Galen and the history of ancient medicine

11 June 2024

224

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects

11 June 2024

227

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

11 June 2024

233

67

235

Paczkowska A

2009

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

11 June 2024

Molecular Pharmacology

235

44

784

Perez DM

1993

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant

11 June 2024

236

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

G protein-coupled receptor kinases

11 June 2024

239

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Inositol phosphate production following alpha 1-adrenergic, muscarinic or electrical stimulation in isolated rat heart

11 June 2024

240

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Protein kinases that phosphorylate activated G protein-coupled receptors.

11 June 2024

242

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Regulation of G protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain

11 June 2024

244

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

The codon 64 polymorphism of the beta3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients

11 June 2024

245

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

11 June 2024

247

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Physiological consequences of beta-adrenergic receptor disruption

11 June 2024

261

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Alterations in dynamic heart rate control in the beta 1-adrenergic receptor knockout mouse.

11 June 2024

263

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice

11 June 2024

268

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II

11 June 2024

275

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome

11 June 2024

298

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Association of hypertension with beta2- and alpha2c10-adrenergic receptor genotype

11 June 2024

303

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

The genetic determination of left ventricular mass in healthy adults

11 June 2024

304

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Variant of the beta3-adrenergic receptor gene and coronary atherosclerosis in Japanese subjects

11 June 2024

306

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

The Arg16Gly polymorphism of the β2-adrenergic receptor and left ventricular systolic function

11 June 2024

307

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Alpha 1‐adrenergic effects on intracellular pH and calcium and on myofilaments in single rat cardiac cells

11 June 2024

312

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure

11 June 2024

323

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts

11 June 2024

324

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Association of the beta2-adrenergic receptor gene with essential hypertension in the non-Han Chinese Yi minority human population

11 June 2024

334

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes

11 June 2024

337

1 reference

https://api.crossref.org/works/10.1152/PHYSREV.00001.2010

11 June 2024

Identifiers

1 reference

23 August 2017

1 reference